(Q44650258)

5 December 2017

title

In vitro susceptibility of CD4+ and CD8+ T cell subsets to fludarabine (English)

1 reference

5 December 2017

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

31 March 2024

2

Carlos M. Galmarini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14609743

31 March 2024

4

Lars Jordheim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14609743

31 March 2024

6

Charles Dumontet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14609743

31 March 2024

author name string

Romina Gamberale

1

1 reference

5 December 2017

Paula Fernández-Calotti

3

1 reference

5 December 2017

Julio Sánchez-Avalos

5

1 reference

5 December 2017

Jorge Geffner

7

1 reference

5 December 2017

Mirta Giordano

8

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:S0006295203006208?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

https://api.elsevier.com/content/article/PII:S0006295203006208?httpAccept=text/plain

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

31 March 2024

published in

Biochemical Pharmacology

1 reference

5 December 2017

volume

66

1 reference

5 December 2017

issue

11

1 reference

5 December 2017

page(s)

2185-2191

1 reference

The role of fludarabine in hematological malignancies

5 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

31 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome

31 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens

31 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Non-myeloablative stem cell transplantation for congenital immunodeficiencies

31 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies

31 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Nucleoside analogues: mechanisms of drug resistance and reversal strategies.

31 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562.

31 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells

31 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine

31 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Opportunistic infections in patients with chronic lymphocytic leukemia following treatment with fludarabine

31 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Severe immunodeficiency in patients treated with fludarabine monophosphate

31 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011.

31 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Thymic aging and T-cell regeneration

31 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Thymus-independent expansion of T lymphocytes in children after allogeneic bone marrow transplantation

31 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

31 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.

31 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis

31 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Features of apoptotic cells measured by flow cytometry

31 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity

31 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Deoxyadenosine-resistant human T lymphoblasts with elevated 5'-nucleotidase activity

31 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells

31 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Cloning and expression of human deoxycytidine kinase cDNA

31 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes

31 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia

31 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.07.008

31 March 2024

Identifiers

1 reference

5 December 2017

1 reference